- Using Tesla Math, GM’s Buick Unit Should Be Worth $1.1 Trillion
- No, Tesla Does Not Outsell the Mercedes S-Class in the U.S. or Globally
- The 10 Most 'Socialist' States in America
- Will Bendgate Have Any Long-Term Effect on Apple's iPhone 6 Plus Legacy?
- How Will SolarCity (SCTY) Stock Be Affected By The Pricing of Its Convertible Senior Notes?
Zafgen will soon enter a Phase 3 trial for its obesity drug beloranib and expects to have a rich year for data in 2015, said the company's CEO.
The divergence between central banks will continue to offer major opportunities for the dollar to strengthen against the Euro and Japanese yen, said Eric Stein, portfolio manager at Eaton Vance.
Cintas posted first quarter earnings of $0.93 a share on revenue of $1.10 billion.
The biosimilar market will soon be booming as over $80 billion worth of drugs go off patent in the next 7 years, said Amit Munshi, CEO of Epirus Biopharmaceuticals.
Advertisers need to take note that travel bookings made on mobile devices are growing far faster than those made on desktops, said Mollie Spilman, chief revenue officer for Criteo.
The Federal Reserve will likely not raise rates until the second half of 2015 and when they do floating rate notes will respond accordingly.
Endurance International has spent the past year since its IPO focusing on growing its emerging markets and mobile businesses, said the company's CEO Hari Ravichandran.
Burger King's acquisition of Tim Hortons not only lacks synergies, but it is too expensive, said Scott Rothbort, President of LakeView Asset Management.
The smooth launch of Alibaba's IPO spurred international interest and boosted market confidence among individual investors.
Solar power has turned the corner in America and its advance will not be reversed by lower fossil fuel prices, said Lynn Jurich, CEO of Sunrun.